​

Aptose Biosciences (APTO) Stock Forecast, Price Target & Predictions

OverviewOwnershipFinancialsChartTranscripts

APTO Stock Rating

Aptose Biosciences stock's rating consensus is Buy, based on 11 Wall Street analysts. The breakdown includes 0 Strong Buy (0.00%), 10 Buy (90.91%), 1 Hold (9.09%), 0 Sell (0.00%), and 0 Strong Sell (0.00%).

Buy
Total 11 0 1 10 Strong Sell Sell Hold Buy Strong Buy

APTO Price Target Upside V Benchmarks

TypeNameUpside
StockAptose Biosciences-
SectorHealthcare Stocks 24.81%
IndustryBiotech Stocks 65.78%

Price Target Trends

1M3M12M
# Anlaysts---
Avg Price Target---
Last Closing Price$1.71$1.71$1.71
Upside/Downside---
Ratings Trends
DateStrong BuyBuyHoldSellStrong SellTotal
Apr, 2511---2
Mar, 2511---2
Feb, 251----1
Jan, 251----1
Dec, 241----1
Analyst Price Target Forecasts
DateAnalystCompanyPrice TargetPrice when PublishedPrice Target/Price when PublishedPrice Target/Last Closing Price
Analyst Rating Forecasts
DateCompanyPrevious RatingNew RatingRating Change
Jun 11, 2024H.C. WainwrightBuyBuyhold
May 16, 2024Canaccord GenuityBuyBuyhold
Mar 28, 2024Canaccord GenuityBuyBuyhold
Aug 11, 2023RBC CapitalOutperformOutperformhold
Mar 27, 2023Canaccord GenuityBuyBuyhold

Financial Forecast

EPS Forecast

$-8 $-7 $-6 $-5 $-4 $-3 $-2 $-1 $0 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$-7.58$-0.04----
Avg Forecast$-7.68$-1.79$-1.18$-0.73$-0.54$-0.35
High Forecast$-7.68$-1.79$-1.18$-0.73$-0.54$-0.35
Low Forecast$-7.68$-1.79$-1.18$-0.73$-0.54$-0.35
Surprise %-1.30%-97.77%----

Revenue Forecast

$0 $8M $16M $24M $32M $40M Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported------
Avg Forecast--$512.00K$38.86M$5.20M$6.70M
High Forecast--$513.00K$38.86M$5.20M$6.70M
Low Forecast--$511.00K$38.86M$5.20M$6.70M
Surprise %------

Net Income Forecast

$-55M $-44M $-33M $-22M $-11M $0 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$-51.21M$-25.43M----
Avg Forecast$-51.86M$-12.09M$-7.97M$-4.93M$-3.65M$-2.36M
High Forecast$-51.86M$-12.09M$-7.97M$-4.93M$-3.65M$-2.36M
Low Forecast$-51.86M$-12.09M$-7.97M$-4.93M$-3.65M$-2.36M
Surprise %-1.26%110.31%----

APTO Forecast FAQ

Is Aptose Biosciences stock a buy?

Aptose Biosciences stock has a consensus rating of Buy, based on 11 Wall Street analysts. The rating breakdown includes 0 Strong Buy, 10 Buy, 1 Hold, 0 Sell, and 0 Strong Sell, reflecting a consensus that Aptose Biosciences is a favorable investment for most analysts.

What is Aptose Biosciences's price target?

Aptose Biosciences's price target, set by 11 Wall Street analysts, averages - over the next 12 months. The price target range spans from - at the low end to - at the high end, suggesting a potential 0% change from the previous closing price of $1.71.

How does Aptose Biosciences stock forecast compare to its benchmarks?

Aptose Biosciences's stock forecast shows a 0% downside, underperforming the average forecast for the healthcare stocks sector (24.81%) and underperforming the biotech stocks industry (65.78%).

What is the breakdown of analyst ratings for Aptose Biosciences over the past three months?

  • April 2025: 50.00% Strong Buy, 50.00% Buy, 0% Hold, 0% Sell, 0% Strong Sell.
  • March 2025: 50.00% Strong Buy, 50.00% Buy, 0% Hold, 0% Sell, 0% Strong Sell.
  • February 2025: 100.00% Strong Buy, 0% Buy, 0% Hold, 0% Sell, 0% Strong Sell.

What is Aptose Biosciences’s EPS forecast?

Aptose Biosciences's average annual EPS forecast for its fiscal year ending in December 2025 is $-1.18, marking a 2850.00% increase from the reported $-0.04 in 2024. Estimates for the following years are $-0.73 in 2026, $-0.54 in 2027, and $-0.35 in 2028.

What is Aptose Biosciences’s revenue forecast?

Aptose Biosciences's average annual revenue forecast for its fiscal year ending in December 2025 is $512K, reflecting a 0% decrease from the reported $0 in 2024. The forecast for 2026 is $38.86M, followed by $5.2M for 2027, and $6.7M for 2028.

What is Aptose Biosciences’s net income forecast?

Aptose Biosciences's net income forecast for the fiscal year ending in December 2025 stands at $-7.971M, representing a -68.66% decrease from the reported $-25.43M in 2024. Projections indicate $-4.931M in 2026, $-3.648M in 2027, and $-2.364M in 2028.